Dramatically Reducing Imaging-to-Recanalization Time in Acute Ischemic Stroke: Making Choices

In the treatment of acute stroke, we are reasonably sure of certain issues. These are the following: On the other hand, there are issues that we do not fully understand. The key ones are the following: Other relevant issues are related to the imaging technique that is the best, most

[1]  D. Sahani,et al.  Cranial CT with Adaptive Statistical Iterative Reconstruction: Improved Image Quality with Concomitant Radiation Dose Reduction , 2012, American Journal of Neuroradiology.

[2]  R. Nogueira,et al.  Abstract 207: CT Perfusion Increases Time to Reperfusion and May Not Enhance Patient Selection for Endovascular Reperfusion Therapies in Acute Ischemic Stroke , 2012, Stroke.

[3]  M. Hill,et al.  Anesthetic Management and Outcome in Patients during Endovascular Therapy for Acute Stroke , 2012, Anesthesiology.

[4]  B. Furlow.  Computed tomography angiography. , 2012, Radiologic technology.

[5]  A. Demchuk,et al.  Regional Leptomeningeal Score on CT Angiography Predicts Clinical and Imaging Outcomes in Patients with Acute Anterior Circulation Occlusions , 2011, American Journal of Neuroradiology.

[6]  W. Heiss.  The Ischemic Penumbra: Correlates in Imaging and Implications for Treatment of Ischemic Stroke , 2011, Cerebrovascular Diseases.

[7]  Kirsten Shuler,et al.  Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: Definitions and thresholds , 2011, Annals of neurology.

[8]  I. Maldonado,et al.  Rescue, Combined, and Stand-Alone Thrombectomy in the Management of Large Vessel Occlusion Stroke Using the Solitaire Device: A Prospective 50-Patient Single-Center Study Timing, Safety, and Efficacy , 2011, Stroke.

[9]  C. White,et al.  Neurothrombectomy Devices for the Treatment of Acute Ischemic Stroke: State of the Evidence , 2011, Annals of Internal Medicine.

[10]  L. Wilkins.  Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology , 2010, Neurology.

[11]  M. Lev,et al.  CT perfusion imaging of acute stroke: the need for arrival time, delay insensitive, and standardized postprocessing algorithms? , 2010, Radiology.

[12]  P. Verro,et al.  Prolonged Dependence of Ischemic Penumbra on Induced Hypertension , 2009, The neurologist.

[13]  S. Warach,et al.  Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.

[14]  R. Bammer,et al.  Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. , 2008, Radiology.

[15]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[16]  Joseph P. Broderick,et al.  Methodology of the Interventional Management of Stroke III Trial , 2008, International journal of stroke : official journal of the International Stroke Society.

[17]  J. Babb,et al.  Accuracy of the Alberta Stroke Program Early CT Score during the First 3 Hours of Middle Cerebral Artery Stroke: Comparison of Noncontrast CT, CT Angiography Source Images, and CT Perfusion , 2008, American Journal of Neuroradiology.

[18]  Keith Muir,et al.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.

[19]  H. Lutsep,et al.  Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial , 2008, Stroke.

[20]  A. Demchuk,et al.  Incidence of Radiocontrast Nephropathy in Patients Undergoing Acute Stroke Computed Tomography Angiography , 2007, Stroke.

[21]  M. Fisher,et al.  Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials , 2007, Annals of neurology.

[22]  Jeffrey L Saver,et al.  The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis , 2007, Stroke.

[23]  A. Dunn,et al.  Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. , 2006, Brain : a journal of neurology.

[24]  J M Wardlaw,et al.  Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  E. Ringelstein.  Ultrafast magnetic resonance imaging protocols in stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[27]  Ting-Yim Lee,et al.  Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. , 2003, AJNR. American journal of neuroradiology.

[28]  W. Hacke,et al.  Comparison of CT and CT Angiography Source Images With Diffusion-Weighted Imaging in Patients With Acute Stroke Within 6 Hours After Onset , 2002, Stroke.

[29]  G. Boysen,et al.  Early stroke: a dynamic process. , 2001, Stroke.

[30]  A. Thiel,et al.  Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. , 2001, Brain : a journal of neurology.

[31]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[32]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. , 2000, Lancet.

[33]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[34]  R. Dijkhuizen,et al.  Dynamics of cerebral tissue injury and perfusion after temporary hypoxia-ischemia in the rat: evidence for region-specific sensitivity and delayed damage. , 1998, Stroke.

[35]  R. Higashida,et al.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. , 1998, Stroke.

[36]  P Trouillas,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.

[37]  C. Sotak,et al.  The role of spreading depression in focal ischemia evaluated bv dffusion mapping , 1996, Annals of neurology.

[38]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[39]  A. Caplan,et al.  Informed consent for emergency research. , 1995, JAMA.

[40]  C. Olson,et al.  Informed consent in emergency research. Consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers. , 1995, JAMA.

[41]  W Hacke,et al.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. , 1994, AJNR. American journal of neuroradiology.

[42]  G Di Chiro,et al.  Histopathologic correlates of abnormal water diffusion in cerebral ischemia: diffusion-weighted MR imaging and light and electron microscopic study. , 1993, Radiology.

[43]  W D Heiss,et al.  Functional recovery of cortical neurons as related to degree and duration of ischemia , 1983, Annals of neurology.